Best Approach to Mild Pap Abnormalities?

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 3
Volume 6
Issue 3

BETHESDA, Md--A new NCI study will evaluate three techniques to manage atypical squamous cells of undetermined significance that show up on Pap smears, including their cost effectiveness and acceptability to women.

BETHESDA, Md--A new NCI study will evaluate three techniques to manageatypical squamous cells of undetermined significance that show up on Papsmears, including their cost effectiveness and acceptability to women.

The trial will evaluate colposcopy; repeating Pap smears every six months;and human papillomavirus (HPV) testing as a means to differentiate betweenabnormalities that need immediate colposcopy and those that can best befollowed with repeat Pap tests at six-month intervals.

The study enrollment of 7,200 women with mild Pap test abnormalitiesshould be completed next year. Participants will be followed for threeyears. The study centers are the University of Alabama at Birmingham, Universityof Oklahoma, Magee-Womens Hospital, and the University of Washington.

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content